Senate Passes Patent-Reform Bill - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Senate Passes Patent-Reform Bill


ePT--the Electronic Newsletter of Pharmaceutical Technology

Last Tuesday, the US Senate approved the “America Invents Act,” which is intended to reform the nation’s patent system. If it becomes law, the bill will establish a first-to-file system by defining an invention’s effective filing date as the actual filing date of the patent or patent application.

The bill is intended to reduce the backlog of pending patent applications at the US Patent and Trademark Office (USPTO) by providing the office with funds needed to review the applications. The bill also would establish additional USPTO satellite offices.

In addition, the bill would change the US patent system in the following ways:

  • By creating a supplemental examination process
  • By providing increased incentives for government laboratories to commercialize inventions
  • By placing restrictions on false-marking claims (i.e., using a patentee’s name or number on a product without consent)
  • By providing additional patent assistance to small businesses through an ombudsman program.

“The America Invents Act will promote American innovation, create American jobs, and grow America’s economy, all without adding to the deficit,” said Senator Patrick Leahy (D-VT), one of the bill’s sponsors, in a press release. “It is common-sense legislation that will help preserve America’s position as the global leader in invention and innovation.”

“Our patent laws should be in the iPad age, not the sock hop age,” said Senator Orrin Hatch (R-UT), another of the bill’s sponsors, in a press release. “This bill will bring our nation’s patent system squarely into the 21st century and will better position our inventors and entrepreneurs to compete in today’s global economy.”

The Obama administration and the Biotechnology Industry Organization have expressed support for the America Invents Act, which is based on a patent-reform act that Representative Lamar Smith (R-TX) and Representative Howard Berman (D-CA) introduced in the US House of Representatives in 2005. The Senate sent the America Invents Act to the House of Representatives for consideration last Wednesday.

See related Pharm Tech articles:
Senate to Consider Patent-Reform Bill (ePT)

Seeking Patent Reform in Europe (ePT)

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here